News about NeuroSearch A/S

  • Local
  • International
  • Company messages

Popular news

1
Teenager’s Lifesaving TickTracker App Recognized by Department of Health & Human Services
2
Pomerantz Law Firm Announces the Filing of a Class Action against OPKO Health, Inc. and Certain Officers – OPK
3
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness
4
Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP Patients
5
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD
6
Plexus Celebrates the Opening of the Enhanced Penang Design Center
7
InsurTech transactions reach new peak in Q2; 5-year Life & Health InsurTech investment exceeds $5 billion
8
CADWorx® & Analysis Solutions releases new CADWorx Design Review Professional for model visualization and publishing
9
Youth INC and RBC Host Fourth Annual Community Event and Raise $1.7M for NYC Youth
10
Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 September 2018 20:48:09
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180919.1 - EUROWEB7 - 2018-09-25 21:48:09 - 2018-09-25 20:48:09 - 1000 - Website: OKAY